Heparin Sodium Injection, Solution
Product Images NDC 51662-1460

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Heparin Sodium (NDC 51662-1460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage 1 (Dosage 1)

Dosage 1 (Dosage 1)
This is a table presenting different recommended dosage, methods of administration and frequency for therapeutic anticoagulant using full-dose heparin on adult patients. The table provides guidance on the recommended dosage for different modes of administration including deep subcutaneous injection, intermittent intravenous injection and intravenous infusion. It also suggests the recommended frequency for each mode of administration.*
FDA Label Image

Dosage 2 (Dosage 2)

Dosage 2 (Dosage 2)
This text provides dosing information for heparin, a commonly used anticoagulant medication. The initial dose is recommended to be 75 to 100 units/kg administered via an intravenous bolus over ten minutes. The text provides specific maintenance dose recommendations based on patient age and weight, with infants less than two months old requiring the highest dose of 25 to 30 units/kg/hour. Children over one year old typically require 18 to 20 units/kg/hour but may require less as they get older and approach adult weight. The text emphasizes the importance of monitoring heparin therapy by adjusting the dose to maintain a specific range of activated partial thromboplastin time (APTT) that reflects a desired anti-Factor Xa level. Overall, the text provides useful information for clinicians who prescribe and manage heparin therapy in pediatric patients.*
FDA Label Image

Highlights (Highlights 1)

Highlights (Highlights 1)
This text provides instructions for administering a medication through different methods such as subcutaneous and intravenous injection or intravenous infusion, with recommended initial doses and doses for subsequent administrations. It also recommends using a different site for each injection and adjusting the dose based on laboratory monitoring.*
FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
This is a description of two types of CarpujectTM Single-dose cartridges with Luer Lock for the CarpujectTM Syringe System. One is a 0.5mL cartridge with a concentration of 5,000 USP Units/0.5mL and is preservative-free, and the other is a 1 mL cartridge with a concentration of 5,000 USP Units/1 mL. Both come in bins of 50 and are designed to be filled with 2.5 mL of liquid.*
FDA Label Image
FDA Label Image

Serialized Syringe Cartridge Labeling (Serialized Syringe Labeling)

Serialized Syringe Cartridge Labeling (Serialized Syringe Labeling)
This text appears to be a product information label for a cartridge unit of Heparin Sodium injection, distributed by HF Acquisition Co. The label includes a product code (03641LL) and a unique identifier (105343687220), as well as instructions to reference the manufacturer's package insert for more information. The unit is described as sterile with a Luer Lock and contains 5,000 USP units per mL.*
FDA Label Image

Structure (Structure)

FDA Label Image

Syringe Cartridge Label Opt 1 (Syringe Label Opt. 1)

Syringe Cartridge Label Opt 1 (Syringe Label Opt. 1)
The text appears to be a product label for a sterile cartridge unit containing Heparin Sodium Inj., USP IR with a concentration of 5,000 usp unitsmL LIS, derived from porcine intestinal mucosa. It is not intended for lock flush and is for intravenous or subcutaneous use.*
FDA Label Image

Syringe Cartridge Label Opt 2 (Syringe Label Opt. 2)

Syringe Cartridge Label Opt 2 (Syringe Label Opt. 2)
This is a description of a single-use Carpuject containing Heparin Sodium Injection, USP with 5,000 USP units per mL. It is a sterile cartridge unit with Luer Lock that can be used for intravenous or subcutaneous administration. The product is not intended for lock flush use. The source of the Heparin Sodium is Porcine Intestinal Mucosa. The National Drug Code for this product is 0409-1402-27.*
FDA Label Image

Pacsyringe Cartridge Label Opt 3 (Syringe Label Opt. 3)

Pacsyringe Cartridge Label Opt 3 (Syringe Label Opt. 3)
This is a description of a single-use Carpuject with Heparin Sodium Injection, USP TR AR. The Cartridge unit comes with Luer Lock Rxonly, containing 5,000 USP units per mL for intravenous or subcutaneous use. It is not available for lock flush and is made from porcine intestinal mucosa.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.